Vanberra Signal

PATH Biotech

Curated by Signal

Provider of AI-powered platforms for drug discovery and development

Overview

Provider of AI-powered platforms for drug discovery and development. It offers AI model integrated with big omics data from human disease samples and single-cells to discover druggable targets and predict precision therapeutics. It has pipeline of drug candidates for neurological disorders, cancer, and auto-immune diseases.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of devices for remote patient monitoring

    Life Sciences TechnologyIrvine, United States
  • Provider of assay reagents kits and gene panels for epigenetics, genome assembly and research purposes

    Life Sciences TechnologySanta Cruz, United States
  • Developer of an AI-enabled diagnostic device for detecting ear diseases

    Life Sciences TechnologyMadison, United States

About PATH Biotech

What does PATH Biotech do?

Provider of AI-powered platforms for drug discovery and development.

Where is PATH Biotech headquartered?

PATH Biotech is headquartered in Tucson, United States.

When was PATH Biotech founded?

PATH Biotech was founded in 2021.

Which sector is PATH Biotech in?

PATH Biotech operates in Life Sciences Technology.

Who are PATH Biotech's competitors?

Companies similar to PATH Biotech include Lotus Health, Dovetail Genomics, and Otologic Technologies.